Labcorp vs Sotera Health
Labcorp (LH) and Sotera Health (SHC) side by side: how big they are, what they earn, how their shares have moved and what insiders, members of Congress and funds reported. Figures from filings and closing prices; none of this is a view on either stock.
- Market value
- $29.8B
- Last close
- $367.13
- 12 months
- +40.4%
- Market value
- $4.54B
- Last close
- $15.91
- 12 months
- +0.8%
At a glance
- The biggest part of Labcorp's revenue is Diagnostics (78%); at Sotera Health it is Sterigenics (65%).
- By market value, Labcorp ($29.8B) is about 6.6 times Sotera Health ($4.5B).
- Over the last 12 months Labcorp's share price moved +40.4% and Sotera Health's +0.8%; against the S&P 500 that is +34.7 points and −5.0 points.
- In their last fiscal years Labcorp kept 6.3% of revenue as net income and Sotera Health 6.7%.
- In the last 90 days insiders reported 0 open-market purchases at Labcorp and 0 at Sotera Health; members of Congress disclosed 4 trades in Labcorp and 0 in Sotera Health.
- Next results: Labcorp Feb 15, 2027, Sotera Health Feb 22, 2027.
How each one makes money: Labcorp revenue · Sotera Health revenue
Share prices on one chart
Labcorp and Sotera Health, and up to three more you add, drawn on the same scale so you can see which moved more.
Face to face
The figures that separate the two, drawn to the same scale. Every figure is also in the table below.
Size
Market value
Revenue, last fiscal year
Net income, last fiscal year
Every figure
| Labcorp LHNYSE · Health Care Services | Sotera Health SHCNASDAQ · Health Care Services | |
|---|---|---|
| Size and profitability | ||
| Market value | $29.8B | $4.54B |
| Revenue, last fiscal year | $14B | $1.16B |
| Net income, last fiscal year | $877M | $77.9M |
| Net marginNet income as a share of revenue | 6.3% | 6.7% |
| Free cash flow | $1.21B | |
Prices are end-of-day closes, and fundamentals are the companies' last annual figures from their SEC filings: a − or + in the table is a fact of the filing or the close, not a forecast. Market value is the company-level figure at the last close. Counts are of records OQRO holds, by their date; insider history since 2006 comes from the SEC's insider transactions data sets and every filing since. Planned sales under a 10b5-1 plan are counted like other sales.
Compare with another company
Labcorp against
Common questions
How is Labcorp different from Sotera Health?
Labcorp (LH) is in Health Care Services on NYSE, with $14B of revenue in its last fiscal year and a net margin of 6.3%. Sotera Health (SHC) is in Health Care Services on NASDAQ, with $1.16B of revenue in its last fiscal year and a net margin of 6.7%. The biggest part of Labcorp's revenue is Diagnostics (78%); at Sotera Health it is Sterigenics (65%). The table above sets their figures side by side; it compares filings and is not a view on either stock.
How do Labcorp and Sotera Health compare in size?
Labcorp has the larger market value: Labcorp $29.8B and Sotera Health $4.54B, at the last close.
Whose share price rose more over the last 12 months, LH or SHC?
Over the last 12 months Labcorp moved +40.4% and Sotera Health +0.8%. Past price moves say nothing about the future.
Which has had more insider buying, Labcorp or Sotera Health?
Since 2006, Labcorp insiders reported 9 open-market purchases against 0 for Sotera Health. These are counts of what was filed, not a view on either stock.
Do members of Congress trade LH or SHC?
In the last 12 months, members of Congress disclosed 9 trades in Labcorp (LH) and 0 in Sotera Health (SHC).
When did insiders last buy LH and SHC?
Labcorp: Sep 7, 2022. Sotera Health: no open-market purchase on record.
See the record behind any of these
A free account opens the full history of every insider and company since 2006, the screener, alerts, Congress trades and fund moves.
Labcorp pageSotera Health pageRare insider trades this weekAll comparisons
https://oqro.io/compare/lh-vs-shc




